Published in Biol Psychiatry on February 01, 2005
Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Children With ADHD | NCT02167048
Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA (2009) 3.69
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry (2010) 2.53
Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis. Mol Psychiatry (2013) 1.86
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. J Neurodev Disord (2012) 1.73
Attention-deficit/hyperactivity disorder and attention networks. Neuropsychopharmacology (2010) 1.69
Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology (2010) 1.62
Attention-deficit disorder (attention-deficit/ hyperactivity disorder without hyperactivity): a neurobiologically and behaviorally distinct disorder from attention-deficit/hyperactivity disorder (with hyperactivity). Dev Psychopathol (2005) 1.49
Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct (2005) 1.47
Further evidence of dopamine transporter dysregulation in ADHD: a controlled PET imaging study using altropane. Biol Psychiatry (2007) 1.25
Hyperdopaminergia and NMDA receptor hypofunction disrupt neural phase signaling. J Neurosci (2009) 1.18
Consequences of variations in genes that affect dopamine in prefrontal cortex. Cereb Cortex (2007) 1.16
Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels. Synapse (2010) 1.14
Anatomical and functional brain imaging in adult attention-deficit/hyperactivity disorder (ADHD)--a neurological view. Eur Arch Psychiatry Clin Neurosci (2006) 1.02
Noradrenergic control of cortico-striato-thalamic and mesolimbic cross-structural synchrony. J Neurosci (2010) 1.02
Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I. Eur J Nucl Med Mol Imaging (2006) 0.94
Functional genomics of attention-deficit/hyperactivity disorder (ADHD) risk alleles on dopamine transporter binding in ADHD and healthy control subjects. Biol Psychiatry (2012) 0.91
A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment. Brain (2013) 0.89
Irrelevant stimulus processing in ADHD: catecholamine dynamics and attentional networks. Front Psychol (2014) 0.89
Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35. Biol Psychiatry (2010) 0.88
Why most biomedical findings echoed by newspapers turn out to be false: the case of attention deficit hyperactivity disorder. PLoS One (2012) 0.88
Altered pattern of brain dopamine synthesis in male adolescents with attention deficit hyperactivity disorder. Behav Brain Funct (2006) 0.87
Biological and social influences on cognitive control processes dependent on prefrontal cortex. Prog Brain Res (2011) 0.86
Hyperactivity persists in male and female adults with ADHD and remains a highly discriminative feature of the disorder: a case-control study. BMC Psychiatry (2012) 0.84
The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography. JAMA Psychiatry (2014) 0.83
Impaired transcallosally mediated motor inhibition in adults with attention-deficit/hyperactivity disorder is modulated by methylphenidate. J Neural Transm (Vienna) (2008) 0.83
Persistent hyperdopaminergia decreases the peak frequency of hippocampal theta oscillations during quiet waking and REM sleep. PLoS One (2009) 0.83
The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults. Exp Clin Psychopharmacol (2013) 0.82
Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study. Eur J Nucl Med Mol Imaging (2006) 0.81
What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction? Br J Pharmacol (2011) 0.81
Medial temporal lobe functioning and structure in the spontaneously hypertensive rat: comparison with Wistar-Kyoto normotensive and Wistar-Kyoto hypertensive strains. Hippocampus (2010) 0.80
Differences in behavior and activity associated with a poly(a) expansion in the dopamine transporter in Belgian Malinois. PLoS One (2013) 0.78
Upregulated GABA Inhibitory Function in ADHD Children with Child Behavior Checklist-Dysregulation Profile: 123I-Iomazenil SPECT Study. Front Psychiatry (2015) 0.78
Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans. Nucl Med Biol (2013) 0.77
Immunization with DAT fragments is associated with long-term striatal impairment, hyperactivity and reduced cognitive flexibility in mice. Behav Brain Funct (2012) 0.77
New marker using bioimpedance technology in screening for attention deficit/hyperactivity disorder (ADHD) in children as an adjunct to conventional diagnostic methods. Psychol Res Behav Manag (2011) 0.77
Neuroimaging of the dopamine/reward system in adolescent drug use. CNS Spectr (2015) 0.76
Effect of perinatal asphyxia and carbamazepine treatment on cortical dopamine and DOPAC levels. J Biomed Sci (2015) 0.75
Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [(11)C]CIT and target controlled infusion. Ups J Med Sci (2011) 0.75
Diagnosis and characterization of mania: Quantifying increased energy and activity in the human behavioral pattern monitor. Psychiatry Res (2016) 0.75
Association between polymorphisms of the DBH and DAT1 genes and attention deficit hyperactivity disorder in children from Jordan. Exp Ther Med (2010) 0.75
The Relationship between the SNAP-25 Polymorphism and Omission Errors in Korean Children with Attention Deficit Hyperactivity Disorder. Clin Psychopharmacol Neurosci (2017) 0.75
Intracortical motor inhibition and facilitation in adults with attention deficit/hyperactivity disorder. J Neural Transm (Vienna) (2008) 0.75
Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms. J Autism Dev Disord (2017) 0.75
Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A (2011) 6.16
Computerized training of working memory in children with ADHD--a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry (2005) 5.58
Extensive piano practicing has regionally specific effects on white matter development. Nat Neurosci (2005) 4.22
Training of working memory in children with ADHD. J Clin Exp Neuropsychol (2002) 3.60
Increased brain activity in frontal and parietal cortex underlies the development of visuospatial working memory capacity during childhood. J Cogn Neurosci (2002) 2.89
The correlative triad among aging, dopamine, and cognition: current status and future prospects. Neurosci Biobehav Rev (2006) 2.73
Changes in cortical dopamine D1 receptor binding associated with cognitive training. Science (2009) 2.24
Evidence of validity in a new method for measurement of dexterity in children and adolescents. Dev Med Child Neurol (2010) 2.20
[Children with mild mental retardation in the special schools. "Top of the iceberg"?]. Lakartidningen (2005) 2.03
Autism spectrum disorders in children with normal intellectual levels: associated impairments and subgroups. Dev Med Child Neurol (2004) 1.87
The serotonin system and spiritual experiences. Am J Psychiatry (2003) 1.79
Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp (2004) 1.76
Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch Gen Psychiatry (2002) 1.75
Developmental risks and protective factors for influencing cognitive outcome at 5 1/2 years of age in very-low-birthweight children. Dev Med Child Neurol (2002) 1.73
Lighter or heavier than predicted: neural correlates of corrective mechanisms during erroneously programmed lifts. J Neurosci (2006) 1.71
Hand function in relation to brain lesions and corticomotor-projection pattern in children with unilateral cerebral palsy. Dev Med Child Neurol (2009) 1.67
Guideline to regulations for radiopharmaceuticals in early phase clinical trials in the EU. Eur J Nucl Med Mol Imaging (2008) 1.58
Listening to rhythms activates motor and premotor cortices. Cortex (2008) 1.52
Approaches to quantify radioligands that wash out slowly from target organs. Eur J Nucl Med Mol Imaging (2010) 1.52
Severe vitamin D deficiency in pregnant women of Somali origin living in Sweden. Acta Paediatr (2011) 1.52
Long-term effects of botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol (2009) 1.48
The "specific" P-glycoprotein inhibitor Tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2). ACS Chem Neurosci (2010) 1.46
Is outcome of constraint-induced movement therapy in unilateral cerebral palsy dependent on corticomotor projection pattern and brain lesion characteristics? Dev Med Child Neurol (2013) 1.46
Cognitive outcome varies in adolescents born preterm, depending on gestational age, intrauterine growth and neonatal complications. Acta Paediatr (2015) 1.45
Dental caries and oral health behavior in children with attention deficit hyperactivity disorder. Eur J Oral Sci (2007) 1.45
Autism before diagnosis: crying, feeding and sleeping problems in the first two years of life. Acta Paediatr (2013) 1.44
Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain (2006) 1.43
Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand. Neuroimage (2009) 1.42
The role of the striatal dopamine transporter in cognitive aging. Psychiatry Res (2005) 1.42
A retrospective study of dental behavior management problems in children with attention and learning problems. Eur J Oral Sci (2004) 1.40
Grip force coordination during bimanual tasks in unilateral cerebral palsy. Dev Med Child Neurol (2011) 1.40
[Researchers and psychiatrists defending Gillberg's research on ADDH: Karfve's campaign is a form of personal persecution and scientific basis is missing]. Lakartidningen (2003) 1.39
The importance of screening for ADHD in children and adolescents with obesity. Acta Paediatr (2013) 1.39
Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38
The PET radioligand [11C]MePPEP binds reversibly and with high specific signal to cannabinoid CB1 receptors in nonhuman primate brain. Neuropsychopharmacology (2007) 1.34
Imaging and quantitation of cannabinoid CB1 receptors in human and monkey brains using (18)F-labeled inverse agonist radioligands. J Nucl Med (2009) 1.31
Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging. J Med Chem (2008) 1.30
AZD2184: a radioligand for sensitive detection of beta-amyloid deposits. J Neurochem (2009) 1.29
Preterm children have disturbances of white matter at 11 years of age as shown by diffusion tensor imaging. Pediatr Res (2003) 1.26
Using positron emission tomography to facilitate CNS drug development. Trends Pharmacol Sci (2006) 1.26
Structural correlates of preterm birth in the adolescent brain. Pediatrics (2009) 1.22
Visuo-spatial working memory span: a sensitive measure of cognitive deficits in children with ADHD. Child Neuropsychol (2004) 1.22
Clinical validation of 18F-AZD4694, an amyloid-β-specific PET radioligand. J Nucl Med (2012) 1.22
Mobius sequence--a Swedish multidiscipline study. Eur J Paediatr Neurol (2002) 1.20
Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur J Nucl Med Mol Imaging (2009) 1.19
Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride. Synapse (2006) 1.18
Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation. Proc Natl Acad Sci U S A (2002) 1.18
Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage (2007) 1.17
Prevalence of autism in children born to Somali parents living in Sweden: a brief report. Dev Med Child Neurol (2008) 1.13
D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model. Neuroimage (2010) 1.12
PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse (2004) 1.11
Prevalence of autism in children of Somali origin living in Stockholm: brief report of an at-risk population. Dev Med Child Neurol (2010) 1.11
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2. Psychopharmacology (Berl) (2006) 1.10
Dopamine D(1) receptors and age differences in brain activation during working memory. Neurobiol Aging (2009) 1.09
Half-life of receptor occupancy--a meaningless concept. Int J Neuropsychopharmacol (2004) 1.09
Copy number variation characteristics in subpopulations of patients with autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet (2010) 1.08
Disturbances in cardiorespiratory function during day and night in Rett syndrome. Pediatr Neurol (2007) 1.08
Antipsychotic occupancy of dopamine receptors in schizophrenia. CNS Neurosci Ther (2010) 1.07
Effector-independent voluntary timing: behavioural and neuroimaging evidence. Eur J Neurosci (2005) 1.07
PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. Am J Psychiatry (2002) 1.07
Chronic fatigue could be a marker of ADHD in children and adolescents. Acta Paediatr (2010) 1.06
Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain. Synapse (2015) 1.05
Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning. Neuropsychologia (2009) 1.05
[18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenil. Neuroimage (2008) 1.05
Vitamin D and autism: clinical review. Res Dev Disabil (2012) 1.04
Molecular imaging of the dopamine transporter. J Nucl Med (2010) 1.04
Thinking outside a less intact box: thalamic dopamine D2 receptor densities are negatively related to psychometric creativity in healthy individuals. PLoS One (2010) 1.03
Lysosomal trapping of a radiolabeled substrate of P-glycoprotein as a mechanism for signal amplification in PET. Proc Natl Acad Sci U S A (2011) 1.03
Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand. J Neurochem (2010) 1.02
Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET. Neuroimage (2004) 1.02
Measurement of striatal and extrastriatal dopamine transporter binding with high-resolution PET and [11C]PE2I: quantitative modeling and test-retest reproducibility. J Cereb Blood Flow Metab (2008) 1.02
Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET. J Cereb Blood Flow Metab (2006) 1.02
Quantification of 11C-MADAM binding to the serotonin transporter in the human brain. J Nucl Med (2005) 1.02
Dopamine D(2/3) receptor occupancy of apomorphine in the nonhuman primate brain--a comparative PET study with [11C]raclopride and [11C]MNPA. Synapse (2009) 1.01
In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass. Nucl Med Biol (2010) 1.01
Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. Neurochem Int (2010) 1.00
Arrestin3 mediates D(2) dopamine receptor internalization. Synapse (2009) 1.00
Alteration of dopamine D1 receptor-mediated motor inhibition and stimulation during development in rats is associated with distinct patterns of c-fos mRNA expression in the frontal-striatal circuitry. Eur J Neurosci (2004) 1.00
Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2. Eur Neuropsychopharmacol (2005) 0.99
Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients. J Neurol Sci (2007) 0.99
Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents. Neuroimage (2008) 0.99
Sensory abnormalities in autism. A brief report. Res Dev Disabil (2010) 0.99